Oct 7 (Reuters) – The European Medicines Company (EMA) mentioned on Thursday it had authorised U.S. drugmaker Merck & Co Inc’s (MRK.N) manufacturing web site in West Level, Pennsylvania to make Johnson & Johnson’s (JNJ.N) COVID-19 vaccine.
Earlier this 12 months, Merck agreed to make its rival’s shot, after scrapping two of its personal experimental COVID-19 vaccines. read more
The U.S. authorities at the moment invoked the Protection Manufacturing Act to assist equip two Merck vegetation to make the J&J vaccine.
The EMA mentioned Merck’s web site, to turn out to be operational instantly, was anticipated to help the continued provide of J&J’s COVID-19 vaccine within the European Union.
Reporting by Manas Mishra in Bengaluru; Enhancing by Shinjini Ganguli
Our Requirements: The Thomson Reuters Trust Principles.
0 Comments